evidencegaps
Primary study · included by 1 review

Feral 2022

ProbableThe reviews cited this study without a PMID, DOI or NCT, so it is matched by first author and year. Two different studies by the same author in the same year could be merged here.

Included by

Adherence to oral antineoplastic agents, an overview and meta-analysis.
Non-Cochrane · prevalence · 2026 · cited as Feral 2022 · Table 3; Figure 2
Outcome this study informsPooled effectEvidenceCertainty
Cumulative adherence
Adherence measured objectively (MEMS, MPR or PDC) · Study durations varied (<6 months and >=6 months)
Pooled proportion (random-effects, logit) 0.84 [0.78, 0.89]17 studies · 7262 participantsGRADE not reported

1 including review in total.